Viracta Therapeutics, Inc.
Biotechnology ResearchCalifornia, United States11-50 Employees
Viracta is a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide.
Viracta Therapeutics, Inc. uses 8 technology products and services including Matomo, Google Cloud CDN, BootstrapCDN, and more. Explore Viracta Therapeutics, Inc.'s tech stack below.
| Viracta Therapeutics, Inc. Email Formats | Percentage |
| FLast@viracta.com | 49% |
| Last@viracta.com | 1% |
| LFirst@viracta.com | 1% |
| FLast@viracta.com | 49% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Viracta is a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide.
Viracta Therapeutics, Inc. has raised a total of $50M of funding over 10 rounds. Their latest funding round was raised on Nov 05, 2021 in the amount of $50M.
Viracta Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M
Viracta Therapeutics, Inc. has raised a total of $50M of funding over 10 rounds. Their latest funding round was raised on Nov 05, 2021 in the amount of $50M.
Viracta Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M